Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis
Charles J. Fisher, Jerald Sadoff(University of Maryland, Baltimore), Alan S. Cross(University of Maryland, Baltimore), Steven M. Opal(Brown University), Roland M.H. Schein, Gilbert Park(Cleveland Clinic), Sue Stephens(Cleveland Clinic), Jean-François Dhainaut(Apple (Israel)), Edward Warren(Cleveland Clinic), Garrett E. Foulke(Cleveland Clinic), Peter Nightingale(University of Birmingham), Jonathan Cohen(Singapore Maritime Institute), Janice L. Zimmerman, S. Harris(Cleveland Clinic), Edward A. Panacek(Cleveland Clinic), CEES VAN DER LINDEN(Cleveland Clinic), Chris Garrard(Cleveland Clinic), Mark Bodmer(UCB Pharma (United Kingdom)), Jean‐Louis Vincent(Université Libre de Bruxelles)
Cited by 431
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k